芬太尼类药品全流程追溯平台
Search documents
诚迈科技斩获“2025信息技术卓越竞争力上市公司”大奖,多维布局深耕信创产业新蓝海
Quan Jing Wang· 2025-12-15 05:16
Core Viewpoint - Chengmai Technology has been awarded the "2025 Information Technology Excellence Competitive Listed Company" at the 14th China Listed Companies Summit, reflecting strong market confidence in the long-term value of the information innovation industry [1][5] Industry Overview - The information innovation industry is entering a trillion-level market space, presenting a historic opportunity for companies like Chengmai Technology [3] - Chengmai Technology has adopted a differentiated market strategy, focusing on the specific needs and core pain points of various industries [3] Product Matrix and Applications - Chengmai Technology has launched a comprehensive product matrix covering key areas, specifically targeting core application scenarios such as government, education, and healthcare [3] - In the government sector, Chengmai's products are recognized for their technical capabilities and reliability, with successful implementations in national conferences and government information construction [3] Education Sector Engagement - The education sector is seen as a foundation for the information innovation industry, and Chengmai Technology aims to lead in the cultivation of digital talent [4] - The company has integrated resources in software, AI applications, and open-source ecosystems to develop comprehensive talent training solutions for higher education and vocational institutions [4] Healthcare Sector Innovations - The healthcare sector is a critical battlefield for the application of information innovation technologies, with high technical barriers and compliance requirements [4] - Chengmai Technology has developed a full-process traceability platform for fentanyl drugs, utilizing IoT and blockchain technologies to enhance safety and compliance in drug management [4] Strategic Positioning - Chengmai Technology's recognition in the reputation rankings is a result of its commitment to independent R&D and deep industry application [5] - The company is steadily progressing towards becoming a globally influential core enterprise in basic software and ecosystem construction, contributing significantly to the safety and high-quality development of China's digital economy [5]
诚迈科技斩获“2025信息技术卓越竞争力上市公司”大奖
Quan Jing Wang· 2025-12-14 10:27
多维布局深耕信创产业新蓝海 2025年12月11日至12日,由《每日经济新闻》主办的"第十四届中国上市公司峰会"在海南海口盛大召 开。作为系列活动的重要一环,备受业界关注的"2025第十五届中国上市公司口碑榜"于12日晚隆重揭 晓。 教育行业是信创产业发展的基石与人才摇篮。诚迈科技积极投身于此,致力于成为信创数智化人才培养 的领军者。公司整合了信创基础软硬件、人工智能应用以及开源鸿蒙生态三大方向的技术资源,打造了 面向高等院校和职业院校的综合性人才培养解决方案。通过与合作院校共建实验室、开发专业课程、提 供实训平台等方式,为产业持续输送高质量的专业人才。 医疗健康作为关系到国计民生的重要领域,正逐渐成为信创技术落地应用的关键战场,其技术门槛高、 合规要求严。诚迈科技在该领域的布局体现了深厚的技术积淀与场景理解能力。例如,公司开发的"芬 太尼类药品全流程追溯平台",利用物联网技术对药品的领取、调配、使用、回收、销毁等所有环节进 行精准的动态监控与闭环管理。同时,引入区块链技术进行关键数据存证,确保信息不可篡改、全程可 溯,有效提升了特殊药品管理的安全性与合规水平。 由此可见,诚迈科技此次荣膺口碑榜大奖,是其长期 ...
诚迈科技推出芬太尼类药品全流程追溯平台
Zheng Quan Shi Bao Wang· 2025-11-03 04:09
Core Viewpoint - The company has developed a full-process traceability platform for fentanyl-based drugs in collaboration with Huazhong University of Science and Technology, addressing significant management challenges in medical institutions [1][2] Group 1: Platform Development - The platform is designed to provide a closed-loop management solution that complies with national standards, currently tested at the main campus of Huazhong University of Science and Technology [1] - It integrates unique identification codes for each drug, along with smart destruction cabinets and handheld PDAs, enabling real-time data interconnection and cross-verification throughout the drug lifecycle [1][2] Group 2: Management Challenges - Medical institutions face multiple challenges in managing fentanyl drugs, particularly in the complex three-tier management system from the pharmacy to clinical departments, where large quantities and complicated processes complicate oversight [1] - The platform addresses key pain points, including system disconnection, vague handling of leftover liquid, and ensuring traceability of medical actions in high-risk scenarios [2] Group 3: Technological Integration - The platform incorporates drug traceability coding technology aligned with industry standards, ensuring compliance and professional integrity [2] - It is compatible with domestic operating systems such as Tongxin UOS, open-source Hongmeng, and Hongzhi OS, utilizing IoT technology for real-time data uploads and dynamic monitoring of drug flow [2] - Blockchain technology is employed to ensure data integrity and prevent tampering, enhancing the overall security of the management process [2] Group 4: Implementation Results - Initial testing at Huazhong University of Science and Technology has shown positive results, achieving the goal of replacing traditional manual verification with technological solutions, thereby improving drug management efficiency and safety [2]